Lobbying registrant · LD-2 disclosures
Crispr Therapeutics, Inc.
Massachusetts
29 filings · 1 client · 2 lobbyists registered · 2019–2026 · latest filed May 4, 2026
Fees billed to clients
$0
never billed a fee — files for itself
Its own lobbying spend
$1.1M
filed on its own behalf
Clients represented
1
2 lobbyists registered
Note · At least one filing discloses a foreign entity with an interest in a client this registrant represents. Those disclosures are listed below.
Reported spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who they lobby for
This registrant files only on its own behalf — it has never reported a fee for representing anyone else.
Reported as lobbying expenses
Money reported as spent on lobbying rather than as a fee charged to a client.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medicare/Medicaid
MMM · 1 client
16 filings
$1.1M on those filings
Health Issues
HCR · 1 client
11 filings
$930K on those filings
Pharmacy
PHA · 1 client
Who does the lobbying
Every lobbyist named on this registrant's filings.
- John MartinCovered position: Head of Government Affairs13 filings1 client · through 2021
- Casey CaldwellCovered position: Head of Government Affairs6 filings1 client · through 2022
Covered positions · 2 of 2 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Foreign interests disclosed
Every foreign entity named on this registrant's filings.
Crispr Therapeutics Ag
Switzerland
3 filings
through 2021
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
The filings
The 20 most recent of 29 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: crispr-therapeutics-inc.